On this page you'll find media statements issued by MSWA containing information about events, fundraising, investment in research, services and facilities and corporate news. Media outlets are welcome to follow up with us for further information.
29 November 2023 A world-leading clinical trial will seek to reverse neurological damage caused by primary progressive multiple sclerosis (PPMS) in Australians living with the debilitating condition, in an announcement made today at the MS Australia Progress in Research Conference in Perth. Read more >
5 July 2023 New clues found in hunt for MS cure. MSWA's Chief Marketing Officer to interview Dr. Fabis-Pedrini on the revolutionary MS research breakthrough. Read more >
2 December 2022 MSWA's 2022-2023 commitment to neurological research. Read more >